Results from the EVOO and ROO groups showed no significant changes in PON-1 activity among healthy participants, and a slight increase in post-MI patients (mean difference compared to baseline = 2.63 ± 36.78 U/mL); however, these changes were not statistically significant. Here, PON1 is linked to myocardial infarction.